Epineuron Technologies Inc.
Epineuron Technologies Inc. is a clinical-stage nerve care company dedicated to revolutionizing nerve recovery through advanced bioelectronic therapy. Their flagship product, the PeriPulse™, is designed to enhance the regeneration of damaged peripheral nerves, offering a drug-free solution that integrates seamlessly into surgical workflows.
Epineuron Technologies Inc.
1875 Buckhorn Gate Suite 602, Mississauga, ON L4W 5P1, Canada
What We Do
A groundbreaking bioelectronic therapy system designed to deliver electrical impulses directly to damaged nerves, promoting regeneration and recovery.
Application Area
Digital Health Technologies
Key People
News & Updates
Building on the success of the clinical pilot study, the company announces regulatory approval for their novel nerve stimulation system.
Epineuron jumpstarts REGAIN™, a pivotal trial evaluating its bioelectronic device to treat nerve damage, with the enrollment of its first patient.
Epineuron's dedication to advancing nerve regeneration will revolutionize the field and change the standard of care when dealing with nerve injuries.
Epineuron's PeriPulse™ Nerve Stimulation System received approval from Health Canada, marking a significant milestone for the company.
Epineuron holds multiple patents for the PeriPulse™ technology, covering its design, functionality, and manufacturing processes.